HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Too, Inc. phases out Mishmash

This article was originally published in The Rose Sheet

Executive Summary

Too, Inc. is phasing out its 18 Mishmash retail stores targeted to tweens to develop a new concept focused on value-priced sportswear and accessories for girls seven to 14. Mishmash has not reached financial objectives as quickly as planned, the company explains. Mishmash locations not converted to the new store concept will be closed permanently. Newly formatted stores are expected to begin opening in February 2004, company says. The format change is prompted by tween demand for inexpensive clothes, and the perception of high prices within Too's stores, firm notes. Too, Inc. opened its first Mishmash store in 2001. At the time, the company predicted the cosmetics and accessories retailer could become a 650- to 700-store chain (1"The Rose Sheet" Oct. 8, 2001, p. 5)...

You may also be interested in...



Too Inc. Retail Concept Brings Mishmash Of Products To Teen Market

Too Inc.' s new retail concept Mishmash, offering teens a diverse merchandising mix including cosmetics, shoes and intimate apparel, eventually could become a 650-700 store chain, The Limited division said.

China Commits To Patent Linkage And Extensions In US Trade Deal

The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions. 

 

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

UsernamePublicRestriction

Register

RS011251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel